These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34635984)

  • 1. The MEK 1/2 inhibitor PD98059 exhibits synergistic anti-endometrial cancer activity with paclitaxel in vitro and enhanced tissue distribution in vivo when formulated into PAMAM-coated PLGA-PEG nanoparticles.
    Wiwatchaitawee K; Mekkawy AI; Quarterman JC; Naguib YW; Ebeid K; Geary SM; Salem AK
    Drug Deliv Transl Res; 2022 Jul; 12(7):1684-1696. PubMed ID: 34635984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel anticancer activity is enhanced by the MEK 1/2 inhibitor PD98059 in vitro and by PD98059-loaded nanoparticles in BRAF
    Mekkawy AI; Naguib YW; Alhaj-Suliman SO; Wafa EI; Ebeid K; Acri T; Salem AK
    Int J Pharm; 2021 Sep; 606():120876. PubMed ID: 34252520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinoma.
    Liang C; Yang Y; Ling Y; Huang Y; Li T; Li X
    Bioorg Med Chem; 2011 Jul; 19(13):4057-66. PubMed ID: 21641806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
    Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
    Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoformulation of Paclitaxel: Exploring the Cyclodextrin / PLGA Nano Delivery Carrier to Slow Down Paclitaxel Release, Enhance Accumulation
    Ma P; Huang J; Liu J; Zhu Y; Chen J; Chen J; Lei L; Guan Z; Ban J; Lu Z
    J Cancer; 2023; 14(5):759-769. PubMed ID: 37056390
    [No Abstract]   [Full Text] [Related]  

  • 6. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile.
    Rafiei P; Haddadi A
    Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Codelivery of Paclitaxel and Everolimus at the Optimal Synergistic Ratio: A Promising Solution for the Treatment of Breast Cancer.
    Houdaihed L; Evans JC; Allen C
    Mol Pharm; 2018 Sep; 15(9):3672-3681. PubMed ID: 29863881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
    Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R
    Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface Modification of Nanoparticles Enhances Drug Delivery to the Brain and Improves Survival in a Glioblastoma Multiforme Murine Model.
    Wiwatchaitawee K; Ebeid K; Quarterman JC; Naguib Y; Ali MY; Oliva C; Griguer C; Salem AK
    Bioconjug Chem; 2022 Nov; 33(11):1957-1972. PubMed ID: 35041398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
    Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
    Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-loaded poly(glycolide-co-ε-caprolactone)-b-D-α-tocopheryl polyethylene glycol 2000 succinate nanoparticles for lung cancer therapy.
    Zhao T; Chen H; Dong Y; Zhang J; Huang H; Zhu J; Zhang W
    Int J Nanomedicine; 2013; 8():1947-57. PubMed ID: 23696703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M
    Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
    Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
    Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro evaluation of paclitaxel-loaded MPEG-PLGA nanoparticles on laryngeal cancer cells.
    Gao C; Pan J; Lu W; Zhang M; Zhou L; Tian J
    Anticancer Drugs; 2009 Oct; 20(9):807-14. PubMed ID: 19696655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
    Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas.
    Cheng WT; Ho HO; Lin SY; Liu DZ; Chen LC; Sheu MT
    Int J Nanomedicine; 2021; 16():6825-6841. PubMed ID: 34675510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.